Determinants of development of permanent atrial fibrillation and its treatment
Authors:
Open Access
- 1 January 1999
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 1 (1) , 35-39
Abstract
We evaluated the rate of progression of permanent atrial fibrillation (AF) and identified clinical factors that predict this event in 63 consecutive patients who had undergone AV junctional ablation and DDDR pacemaker implantation for drug-refractory paroxysmal atrial fibrillation/flutter. Immediately after ablation, anti-arrhythmic drugs were discontinued in all cases. Permanent AF was con-sidered to have developed if AF was present on two consecutive 6-monthly examinations with no interim documented sinus rhythm. During a mean follow-up of 23±16 months, 22 (35%) of the 63 patients developed permanent AF. The actuarial estimate of progression of permanent AF was 22%, 40% and 56%, respectively, 1, 2 and 3 years after ablation. Age and underlying heart disease were independent predictors of progression of permanent AF. Only one (6%) of 16 patients with idiopathic AF had permanent AF (low risk group). Among the 47 patients with structural heart disease, permanent AF developed in 18 (62%) of the 29 who were aged >75 years or had >12 arrhythmic episodes per year and a symptom duration >4 years (high risk group), but only in three (17%) of the remaining 18 patients who did not (intermediate risk group). In conclusion, during a 3-year follow-up period, about half of the patients with a history of drug-refractory paroxysmal AF did not develop permanent AF after AV junctional ablation and dual-chamber pacemaker implantation, even in the absence of anti-arrhythmic drug therapy. Moreover, subgroups of patients whose risk of permanent AF progression differed were identified on the basis of simple baseline clinical variables. The results of this study form the necessary background for the correct management of patients after AV junction ablation and for the planning of future trials in this field.Keywords
This publication has 14 references indexed in Scilit:
- Assessment of Atrioventricular Junction Ablation and DDDR Mode-Switching Pacemaker Versus Pharmacological Treatment in Patients With Severely Symptomatic Paroxysmal Atrial FibrillationCirculation, 1997
- Atrial rhythm after atrioventricular junctional ablationThe American Journal of Cardiology, 1996
- Dual-Chamber Versus Ventricular PacingCirculation, 1996
- Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: Impact of treatment in paroxysmal and established atrial fibrillationAmerican Heart Journal, 1996
- Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episodeThe American Journal of Cardiology, 1995
- Long‐Term Follow‐Up of Patients Treated By Radiofrequency Ablation of the Atrioventricular JunctionPacing and Clinical Electrophysiology, 1995
- Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndromeThe Lancet, 1994
- Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities.Circulation, 1993
- Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1991
- Clinical features of paroxysmal atrial fibrillation an observation of 94 patients.Japanese Heart Journal, 1981